Concepedia

Theresa J. Roethke

TJ

Statistics

Publications

20

Citations

1K

H-Index

17

Active since

1999

Affiliations

GlaxoSmithKline (United States)(Current)

South College

GlaxoSmithKline (United Kingdom)

Pathways Behavioral Services

Discovery Centre

Theresa J. Roethke is an author at GlaxoSmithKline (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

1999–2024

20

Publications

20

An Orally Active TRPV4 Channel Blocker Prevents and Resolves Pulmonary Edema Induced by Heart Failure

Kevin S. Thorneloe, Mui Cheung, Weike Bao et al. · Science Translational Medicine · 2012 · 336 citations

, , +10

Discovery of GSK2193874: An Orally Active, Potent, and Selective Blocker of Transient Receptor Potential Vanilloid 4

Mui Cheung, Weike Bao, David J. Behm et al. · ACS Medicinal Chemistry Letters · 2017 · 99 citations · Full text

, , +10

Structure Activity Relationships of 5-, 6-, and 7-Methyl-Substituted Azepan-3-one Cathepsin K Inhibitors

Dennis S. Yamashita, Robert W. Marquis, Ren Xie et al. · Journal of Medicinal Chemistry · 2006 · 71 citations · Full text

, , +15

Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolase

Reema K. Thalji, J. Jeffrey McAtee, Svetlana Belyanskaya et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 64 citations · Full text

, , +11

Discovery of GSK2798745: A Clinical Candidate for Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4)

Carl Brooks, Linda S. Barton, David J. Behm et al. · ACS Medicinal Chemistry Letters · 2019 · 56 citations · Full text

, , +17

1–5 of 20